Charts
24 Mar, 2023
23 Mar, 2023
22 Mar, 2023
21 Mar, 2023
20 Mar, 2023
17 Mar, 2023
15 Mar, 2023
14 Mar, 2023
10 Mar, 2023
12:44
Seeking Alpha
News
13 Mar, 2023
Gainers
Provention Bio (NASDAQ:PRVB) stock moved upwards by 260.1% to $24.12 during Monday's regular session. As of 13:30 EST, ...
09 Mar, 2023
12:30
Yahoo! Finance
On track to provide clinical update from dose-escalation portion of Phase 1 clinical trial of EGFR MasterKey inhibitor BDTX-1535 in the second half of 2023 FDA clearance of IND application for BDTX-4933 in the first quarter of 2023, a brain-penetrant RAF MasterKey inhibitor for the treatment of all-class RAF and RAS mutant tumors; initiation of Phase 1 clinical trial expected in the first half of 2023 Presented new preclinical data demonstrating the potential of MasterKey programs BDTX-1535 and
27 Feb, 2023
13:00
Yahoo! Finance
CAMBRIDGE, Mass. and NEW YORK, NY, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing novel MasterKey therapies targeting families of oncogenic driver mutations in patients with genetically defined cancers, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the Cowen 43rd Annual Health Care Conference on Monday,
15 Feb, 2023
10:46
Yahoo! Finance
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
19 Jan, 2023
18:33
FinancialContent
Gainers
Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed ...
Gainers
BeyondSpring (NASDAQ:BYSI) stock moved upwards by 24.4% to $2.7 during Thursday's regular session. Trading volume for ...
10:41
Yahoo! Finance
A look at the shareholders of Black Diamond Therapeutics, Inc. ( NASDAQ:BDTX ) can tell us which group is most...
05 Jan, 2023
13:00
Yahoo! Finance
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies designed to overcome limitations of existing therapies by targeting families of oncogenic driver mutations in patients with genetically defined cancers, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the 41st
29 Dec, 2022
Gainers
Quotient (NASDAQ:QTNT) stock moved upwards by 114.0% to $0.49 during Thursday's pre-market session. The market value of their ...
19 Dec, 2022
CAMBRIDGE, Mass. and NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that Chairman of the Board of Directors, Robert (Bob) A. Ingram, has stepped down due to personal reasons. Existing Board member, Mark Velleca, M.D., Ph.D., has been appointed to succeed Mr. Ingram as the next Chairman. “Bob’s counsel, expertise and partnership have
12 Dec, 2022
13:00
Yahoo! Finance
- $30M Series A investment from Versant Ventures and NEA- CAMBRIDGE, Mass. and NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the formation of Launchpad Therapeutics, Inc. (Launchpad), an antibody-focused precision oncology company, together with a $30 million Series A investment by founding investors, Versant Ventures and New Enterp
09 Dec, 2022
14:35
Yahoo! Finance
Black Diamond (BDTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
14:04
Yahoo! Finance
Insiders who bought US$61k worth of Black Diamond Therapeutics, Inc.'s ( NASDAQ:BDTX ) stock at an average buy price of...
06 Dec, 2022
09 Nov, 2022
CAMBRIDGE, Mass. and NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Master Key therapies, today announced that company management will participate in three upcoming investor conferences: The H.C. Wainwright 3rd Annual Precision Oncology Virtual Conference. The fireside chat will take place on Monday, November 14, 2022, at 12:00 PM ET.The Stifel 2022 Healthcare Conferenc
08 Nov, 2022
13:00
Yahoo! Finance
Presented new data at the 34th EORTC-NCI-AACR Symposium highlighting robust preclinical anti-tumor activity of BDTX-1535 and BDTX-4933 across multiple families of oncogenic mutations while sparing wild type; both MasterKey therapies demonstrate key attributes of next generation small molecule inhibitorsOn track to provide a clinical update on BDTX-1535 in 2023 and to file an IND for BDTX-4933 in the first half of 2023Strengthened clinical development leadership with appointment of Melanie Morris
03 Nov, 2022
15:42
FinancialContent
The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When ...
01 Nov, 2022
11:52
FinancialContent
The Dow Jones closed lower by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.
When ...
26 Oct, 2022
12:00
Yahoo! Finance
BDTX-1535 is an irreversible MasterKey inhibitor of multiple EGFR alterations that utilize similar activated oncogenic EGFR conformations to drive tumor cell growth in GBM and NSCLC BDTX-1535 demonstrated potent systemic and CNS anti-tumor activity and survival benefit in multiple PDX models of GBM and NSCLC tumors driven by a family of EGFR alterations, including resistance mutations and EGFR amplification BDTX-4933 is a MasterKey inhibitor of oncogenic isoforms of the RAF family, which demonst
24 Oct, 2022
19:57
FinancialContent
The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders ...
14 Oct, 2022
11:34
FinancialContent
Gainers
Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around ...
28 Aug, 2022
13:41
Yahoo! Finance
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
16 Aug, 2022
In recent trading, shares of Black Diamond Therapeutics Inc (BDTX) have crossed above the average analyst 12-month target price of $4.00, changing hands for $4.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..
09 Aug, 2022
Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM.
Here's ...
12:00
Yahoo! Finance
Strengthened leadership team with appointment of Sergey Yurasov, M.D., Ph.D., as Chief Medical OfficerAdvanced MasterKey therapy pipeline with first patient dosed in Phase 1 global study of BDTX-1535, and continued IND-enabling studies of BDTX-4933Cash, cash equivalents and investments of approximately $160.9 million as of June 30, 2022; expected to be sufficient to fund operations into the third quarter of 2024 CAMBRIDGE, Mass. and NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Black Diamond Thera
03 Aug, 2022
12:00
Yahoo! Finance
CAMBRIDGE, Mass. and NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will participate in a panel discussion titled, Bullseye - Targeted Oncology - Quanta of Targets, at the Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022, at 10:20 a.m.
01 Aug, 2022
12:55
Yahoo! Finance
The big shareholder groups in Black Diamond Therapeutics, Inc. ( NASDAQ:BDTX ) have power over the company. Generally...
09 Jul, 2022
02 Jul, 2022
12:29
Yahoo! Finance
Whilst it may not be a huge deal, we thought it was good to see that the Black Diamond Therapeutics, Inc. ( NASDAQ:BDTX...
01 Jul, 2022
U.S. stocks opened slightlylower on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders ...
06 Jun, 2022
12:00
Yahoo! Finance
CAMBRIDGE, Mass. and NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the Jefferies Global Healthcare Conference on Wednesday, June 8, 2022, at 3:00pm ET in New York, NY. A live webcast of the presentation can be
03 Jun, 2022
01 Jun, 2022
11:00
Yahoo! Finance
- Dr. Yurasov brings over 25 years of experience in oncology drug development and regulatory expertise - CAMBRIDGE, Mass. and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the appointment of Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer. In conjunction with the appointment of Dr. Yurasov, Karsten Witt, M.D., is transitioning
26 May, 2022
17 May, 2022
11:00
Yahoo! Finance
CAMBRIDGE, Mass. and NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the H.C. Wainwright Global Investment Conference. The presentation will be available for on-demand viewing starting Tuesday, May 24, 2022 at 7:
11 May, 2022
Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:30 PM.
Here's what investors ...
02 May, 2022
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase ...
25 Apr, 2022
17:43
FinancialContent
Black Diamond Therapeutics Inc(NASDAQ: BDTX) is realigning its resources to extend its cash runway into the third quarter of ...
21 Apr, 2022
US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell ...
18 Apr, 2022
13:17
Seeking Alpha
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or ...
08 Apr, 2022
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a ...
07 Apr, 2022
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million ...
29 Mar, 2022
Upgrades
According to OTR Global, the prior rating for Illumina Inc (NASDAQ:ILMN) was changed from Mixed to Positive. For the fourth ...
17 Mar, 2022
02 Mar, 2022
Wednesday's session saw 107 companies set new 52-week lows.
Points of Interest From Today's 52-Week ...
18 Feb, 2022
Gainers
Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The ...
09 Feb, 2022
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 ETF (VTWO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $110.34 per unit.
12 Jan, 2022
11 Jan, 2022
Black Diamond Therapeutics Inc (NASDAQ: BDTX) is trading higher Tuesday after the companyannounced it receivedU.S. Food and ...
13:20
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
BioAtla, Bristol-Myers ...
Gainers
Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market ...
08 Nov, 2021
25 Oct, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Biotechnology ETF (IBB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $199.20 per unit.
08 Oct, 2021
11:31
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
07 Oct, 2021
12:23
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
06 Oct, 2021
11:33
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
05 Oct, 2021
12:01
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
01 Oct, 2021
11:56
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA ...
30 Sep, 2021
Upgrades
For Cabot Oil & Gas Corp (NYSE:COG), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the ...
23 Sep, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $289.42 per unit.
21 Sep, 2021
23 Aug, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Value ETF (VBR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $195.61 per unit.
12 Aug, 2021
10 Aug, 2021
27 Jul, 2021
11:48
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
22 Jul, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 3000 ETF (VTHR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $221.01 per unit.
16 Jul, 2021
11:37
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
15 Jul, 2021
12:07
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
14 Jul, 2021
11:48
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
13 Jul, 2021
Before 10 a.m. ET on Tuesday, 48 companies set new 52-week lows.
Interesting Highlights:
Marqeta ...
09 Jul, 2021
11:36
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
08 Jul, 2021
11:45
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting ...
07 Jul, 2021
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..
11:41
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting ...
02 Jul, 2021
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows.
Points of Interest:
Autohome (NYSE:ATHM) ...
01 Jun, 2021
20 May, 2021
07 May, 2021
29 Mar, 2021
25 Mar, 2021
20 Nov, 2020
10 Nov, 2020
26 Oct, 2020
23 Oct, 2020
12 Oct, 2020
11 Aug, 2020
